Adastra Pharmaceuticals
Adastra is committed to transforming cancer care.
Adastra is committed to transforming cancer care.
Adastra Pharmaceuticals Inc. is a pioneering force in the biotechnology, health care, and pharmaceutical industries. Since its establishment in 2005, the company has been steadfast in its commitment to revolutionizing cancer care. Adastra's unwavering dedication is encapsulated in their slogan "Adastra is committed to transforming cancer care." The company's innovative approach has led to it being a clinical-stage biopharmaceutical firm with a focus on providing responsible solutions to advance patient care in oncology. Adastra's vision is centered around identifying, developing, and delivering important new therapies for diseases with significant unmet needs. Their last investment round saw them secure an impressive $3.26M, a testament to the trust placed in the company's mission. This Venture Round investment took place on 15 November 2016. Based in the United States, Adastra Pharmaceuticals is positioned to make a substantial impact in the field of oncology and beyond.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $3.26M | - | 15 Nov 2016 | |
| Venture Round | $13.06M | - | 28 Aug 2015 | |
| Series C | $4.80M | 1 |
|
01 Aug 2015 |
| Debt Financing | $1.20M | - | 17 Jul 2015 | |
| Convertible Note | $1.32M | 1 |
|
01 Jul 2015 |
No recent news or press coverage available for Adastra Pharmaceuticals.
We care about your data, and we'd love to use cookies make your experience better.